Compound Detail
CHEMBL3545157
TIDEGLUSIB 🧪 Phase II
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase II
Basic Information
| ChEMBL ID | CHEMBL3545157 |
| Name | TIDEGLUSIB |
| Phase | Phase II |
| Structure Type | MOL |
| InChI Key | PMJIHLSCWIDGMD-UHFFFAOYSA-N |
6
Targets
25
Activities
1
Assay Types
1
PK Parameters
20
Publications
5
Known Names
5
Indications
1
Mechanisms
Molecular Properties
334.4
MW (Da)
3.26
ALogP
5
HBA
0
HBD
44.0
PSA (Ų)
0.58
QED
0
Ro5 Violations
3
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Glycogen synthase kinase-3 beta inhibitor | INHIBITOR | Glycogen synthase kinase-3 beta | ✓ | ✓ |
Indications
Alzheimer Disease Amyotrophic Lateral Sclerosis Child Development Disorders, Pervasive Myotonic Dystrophy Myotonic Dystrophy
Activity Summary
IC50 25 meas. best 8.3
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Glycogen synthase kinase-3 beta CHEMBL262 | IC50 | 8.3 | 6.7511 | 5.0 | 9 |
| Replicase polyprotein 1ab CHEMBL4523582 | IC50 | 7.1 | 6.2644 | 80.0 | 9 |
| Sortase A CHEMBL5362 | IC50 | 6.22 | 5.725 | 600.0 | 2 |
| SARS-CoV-2 CHEMBL4303835 | IC50 | 6.17 | 6.17 | 670.0 | 1 |
| Histone deacetylase 6 CHEMBL1865 | IC50 | 6.0 | 6.0 | 992.9 | 1 |
| Unchecked CHEMBL612545 | IC50 | 5.81 | 5.78 | 1550.0 | 3 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| Cmax | 409.69 | nM | Mus musculus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine